Two and a half years ago, in 2015, Biotechnology Journal released a special issue [1] on Mammalian Production Systems with an Editorial entitled "On the cusp of rational cell engineering." This title was chosen to express the expectancy, arising from recent developments such as the release of the CHO and Chinese hamster genomes, to understand in unprecedented detail the molecular and biochemical mechanisms at work in mammalian cell lines used for the production of biopharmaceutics. Since then, we have seen the publication of genome sequences for several more cell lines, of a plethora of transcriptome and proteome datasets and the first exploration of the impact of epigenetics on cellular behavior in bioprocessing, along with the advent of highly efficient and targeted genome editing tools such as CRISPR/Cas9, which have considerably enhanced the scope and speed of cell line engineering.Due to the importance of biopharmaceutics for research, medicine and industry, the European Union realized the urgency of having appropriately trained individuals in their workforce, able to handle the associated multi-disciplinary challenges. Therefore, an International Training Network on "enhancing CHO by systems biology," in short eCHO, was established within the EU Marie-Curie Actions Program, to train 15 PhD students in the diverse fields of computational biology and modeling, cell culture technology and cell line engineering within the period of 2015 to 2018 (www.echo-systems.eu). Part of the training includes entrepreneurial training and a secondment to one of the numerous industrial partners to ensure that graduates of this program are exposed to and familiar with both the academic (more exploratory, and oriented toward generation of understanding and of algorithms and rules) and industrial realities (in part as adventurous and aiming toward understanding, but more restricted by the necessity to follow regulatory and safety considerations).In this special issue we wanted to capture the advances made since 2015 and to evaluate whether the expectancy was indeed met in reality. A brief call for paper submissions to the players in the field was met with such success that the number of proposed contributions was soon outside the scope of a single issue. It was therefore decided that Biotechnology Journal would in 2018 see two issues on the topic of "enhancing CHO by systems biotechnology" including several contributions from industrial authors, demonstrating that this is not a merely academic playground, but has in the meantime reached industrial relevance and reality. These two issues will also contain 11 manuscripts written by the ESRs (Early Stage Researchers) of the eCHO Training Network, to present a brief glimpse into the diverse work and data generated by this program (these are marked with an asterisk below).In this first issue, several reviews summarize the state of the art: Stolfa et al.[2] give a comprehensive overview over the impact of systems biology on CHO based bioproduction and also summarize the available res...